Soria, May N.
HRN: 14-43-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
08/03/2023
08/09/2023
IVTT
500 Mg
1 Dose
For Elective OR (cholecystectomy)
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes